AMH and granular cell tumor: A limited number of other studies analyzing 20 to 40 samples each and using Western-blot, RT-PCR, or IHC with monoclonal, polyclonal antibodies, or biotinylated AMH confirmed AMHRII expression in 50% to 85% of EOC [16], 96% to 100% of GCT [24,25] [14,16], and 100% of cervical cancers [15].